title: [Predictive value of the early metabolic response in patients with advanced-stage non-small cell lung cancer].
authors.affiliation: CETIR Unitat PET/TC, Esplugues, Barcelona, España.
authors.forename: C
authors.initials: C
authors.lastname: Moreno
authors.affiliation: CETIR Unitat PET/TC, Esplugues, Barcelona, España.
authors.forename: S
authors.initials: S
authors.lastname: Mourelo
authors.affiliation: CETIR Unitat PET/TC, Esplugues, Barcelona, España.
authors.forename: M
authors.initials: M
authors.lastname: Soler
authors.affiliation: CETIR Unitat PET/TC, Esplugues, Barcelona, España.
authors.forename: M
authors.initials: M
authors.lastname: Moragas
authors.affiliation: CETIR Unitat PET/TC, Esplugues, Barcelona, España.
authors.forename: E
authors.initials: E
authors.lastname: Riera
authors.affiliation: CETIR Unitat PET/TC, Esplugues, Barcelona, España. Electronic address: jrgarcia@cetir.es.
authors.forename: J R
authors.initials: JR
authors.lastname: Garcia
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism*; D000069347:Erlotinib Hydrochloride / Q000627:therapeutic use*; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism*; D064847:Multimodal Imaging; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography; D011237:Predictive Value of Tests; D019275:Radiopharmaceuticals; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D000069347:Erlotinib Hydrochloride